Denfos 35mg Tablet contains alendronic acid (also known as alendronate sodium), a bisphosphonate medicine used to treat and prevent osteoporosis and other conditions associated with bone loss. Osteoporosis weakens bones by reducing bone density and increasing fracture risk, particularly in the spine, hip, and wrist. Alendronic acid works by slowing bone breakdown, helping maintain bone strength and reducing the risk of fractures. Denfos 35mg Tablet may be prescribed alone or alongside calcium and vitamin D supplementation, especially in postmenopausal women, older adults, and patients receiving long-term steroid therapy.
Written by: Shubham Kumar Singh, B pharmacy
Reviewed by: Dr. Jay Faldu, MBBS
Last updated on: 20-05-2026
Delivery by
...
WHO GMP Certified
Long Expiry (>8 Months)
15 Days Easy Returns
Genuine Medicine
Pay On Delivery
Secure Payment
View content in
Denfos 35mg Tablet contains alendronic acid (also known as alendronate sodium), a bisphosphonate medicine used to treat and prevent osteoporosis and other conditions associated with bone loss. Osteoporosis weakens bones by reducing bone density and increasing fracture risk, particularly in the spine, hip, and wrist. Alendronic acid works by slowing bone breakdown, helping maintain bone strength and reducing the risk of fractures. Denfos 35mg Tablet may be prescribed alone or alongside calcium and vitamin D supplementation, especially in postmenopausal women, older adults, and patients receiving long-term steroid therapy.
Denfos 35mg Tablet contains alendronic acid, a bisphosphonate that reduces bone resorption and helps preserve bone mineral density. It is commonly prescribed for postmenopausal osteoporosis, osteoporosis in men, and glucocorticoid-induced osteoporosis, as well as for certain bone disorders such as Paget’s disease of bone.
Bone is constantly renewed through a process involving bone breakdown (resorption) and new bone formation. In osteoporosis, bone breakdown occurs faster than bone formation, leading to fragile bones that fracture more easily. Alendronic acid binds strongly to bone surfaces and inhibits osteoclast activity, the cells responsible for bone resorption. This slows bone loss and allows bone-forming cells to restore strength over time.
Regular treatment with Denfos 35mg Tablet has been shown to improve bone density and significantly reduce the risk of vertebral, hip, and other fractures. Because the medicine works directly on bone tissue and remains there for a long time, weekly dosing is often sufficient for many patients.
To maximise absorption and minimise irritation of the oesophagus, alendronic acid must be taken on an empty stomach with plain water and patients should remain upright for at least 30 minutes afterwards. The medicine usually requires long-term use, and benefits become more apparent over several months of consistent treatment.
Alendronic acid is not metabolised extensively and is excreted unchanged by the kidneys, so patients with severe kidney impairment may need alternative therapy. When used correctly under medical supervision, Denfos 35mg Tablet is an effective long-term treatment for improving bone strength and reducing fracture risk.
Treatment and prevention of bone loss after menopause to reduce fracture risk.
Helps improve bone density and reduce fracture risk in men with osteoporosis.
Used in patients taking long-term corticosteroids that weaken bones.
Helps regulate abnormal bone turnover and improve bone structure.
When taken as directed, Denfos 35mg Tablet is generally effective and well tolerated. Side effects are often mild and improve with correct administration.
Denfos 35mg Tablet should be taken exactly as prescribed by your physician. The standard dose is usually one tablet once weekly, taken on the same day each week. Take the tablet first thing in the morning on an empty stomach with a full glass of plain water. Swallow it whole and remain upright (sitting or standing) for at least 30 minutes afterwards. Do not eat, drink, or take other medicines during this period.
The mechanism of Denfos 35mg Tablet is based on its ability to inhibit osteoclast-mediated bone resorption. Alendronic acid belongs to the bisphosphonate class and binds strongly to hydroxyapatite crystals in bone.
When osteoclasts attempt to break down bone containing alendronic acid, their activity is reduced and they eventually undergo apoptosis (programmed cell death). This decreases bone turnover and allows osteoblasts (bone-forming cells) to build stronger bone over time.
By reducing excessive bone resorption, alendronic acid improves bone mineral density and lowers fracture risk, particularly in areas prone to osteoporotic fractures such as the hip and spine.
While Denfos 35mg Tablet must be taken on an empty stomach, certain foods and supplements strongly affect absorption.
Denfos 35mg Tablet can interact with medicines that affect absorption or bone metabolism.
Denfos 35mg Tablet should be used carefully in patients with certain conditions.
If you miss your weekly dose, take it the next morning after you remember. Then return to your usual weekly schedule. Do not take two tablets on the same day. Missing occasional doses may reduce long-term benefit, so regular adherence is important.
Therapeutic Class
Anti-osteoporotic Agent
Action Class
Osteoclast Inhibitor / Bisphosphonate
Chemical Class
Bisphosphonate
Habit Forming
No
PlatinumRx is committed to providing reliable and accurate information to support informed customer decisions. However, all information made available on the Platform, including product descriptions, comparisons, and other content, is provided solely for general informational purposes. Such information is not intended to diagnose, prevent, treat, or cure any medical condition, nor should it be relied upon as a substitute for professional medical advice, diagnosis, or treatment.
More Medicines By Manufacturer
More Medicines With Salt
Top Selling Medicines
Top Selling Devices